innovation marketplace

TECH OFFERS

Discover new technologies by our partners

Leveraging our wide network of partners, we have curated numerous enabling technologies available for licensing and commercialisation across different industries and domains. Our focus also extends to emerging technologies in Singapore and beyond, where we actively seek out new technology offerings that can drive innovation and accelerate business growth.

By harnessing the power of these emerging technologies and embracing new technology advancements, businesses can stay at the forefront of their fields. Explore our technology offers and collaborate with partners of complementary technological capabilities for co-innovation opportunities. Reach out to IPI Singapore to transform your business with the latest technological advancements.

Guided Trans-Radial Access Catheters - A Surgery Device for Strokes with Faster Treatments
This technology is a neurointerventional procedure, focusing on transradial access for acute ischemic and hemorrhagic stroke treatment. Traditionally, neurointerventions utilize transfemoral access, but this solution leverages the radial artery for access, providing a safer and more comfortable alternative. By reducing complications and shortening recovery times, the transradial approach significantly enhances patient experience.  The transradial access system comprises three components: a radial access sheath, a selective catheter, and a guiding catheter. Each component is designed to work in harmony, ensuring the system’s compatibility and optimal performance. The radial sheath maintains high structural integrity while reducing radial artery spasm and occlusion. The selective catheter offers multiple proprietary tip shapes for improved access to neuro arteries. The guiding catheter combines distal flexibility and proximal stiffness to ensure smooth catheter pushability and trackability, providing surgeons with an efficient and seamless experience. The trans-radial access catheters for neurosurgery are developed for Asian population whom have narrow arteries.  The technology owner is interested in joint R&D projects to co-develop the technology. The neuro transradial access system comprises three core technologies: the radial access sheath, the selective catheter, and the guiding catheter. Radial Access Sheath: Designed with an optimal balance of flexibility and strength to enable precise navigation through the radial artery. Features a low-profile, thin-walled design to minimize radial artery spasm and ensure patient comfort. Coated with a hydrophilic layer to reduce friction, facilitating smoother sheath insertion and advancement. Selective Catheter: Equipped with a proprietary tip shape that enhances access to critical arteries, including the right/left ICA, ECA, and VA. Incorporates a U-shape stiffness for superior anchorage, preventing slippage during procedures and ensuring stability post-subclavian artery access. Guiding Catheter: Optimal balance of distal flexibility and proximal stiffness. Features a multi-layer design: a polymeric outer layer for flexibility, metallic coils and braids in the mid-layer for added structural support, and a high-wear resistance inner layer to ensure smooth catheter movement within the vasculature. Enables superior pushability and trackability during neurointerventions. This technology is designed for use in neurointervention procedures, with potential applications in the following areas: Aspiration Catheter Microcatheter Intermediate Catheter Distal Delivery Catheter This technology offers several advantages over conventional solutions in the neurointerventional space: Shorter Recovery Time: The design of this system reduces procedural complications and promotes faster recovery times, allowing patients to return to their normal activities sooner. Tailored for the Asian Population: The Trans-Radial Access Catheters are specifically designed for the Asian population, accommodating narrower arteries and ensuring safer and more effective neurointerventional access. Complete Neuro Transradial System: A fully integrated system that provides seamless access from the radial artery to the neurovasculature, minimizing procedural complications. Optimized Radial Sheath: Engineered to reduce radial artery spasm and occlusion, improving patient outcomes and comfort. Selective Catheter with Anchoring Mechanism: The catheter’s design prevents slippage during procedures, enhancing stability and precision during treatments. Guiding Catheter Designed for Optimal Pushability and Trackability: this catheter ensures smooth navigation through the vasculature, improving the overall user experience for surgeons. Medical Device, Neurointerventional, Catheters, Transradial Access, Radial Access Sheath, Selective Catheter, Radial Guide Catheter Healthcare, Medical Devices
Clean and Safe Indoor Air Quality Solution Using Far-UVC Technology
In the wake of the COVID-19 pandemic, people have developed new expectations for indoor air quality. It is no longer just about ventilation and purification, but also about providing clean and safe air for a healthier environment. Traditional UVC technology (254 nm) has been widely used in HVAC systems and air purifiers to disinfect airborne pathogens. To ensure its effectiveness, sufficient contact time is required, hence it is often used in unoccupied spaces due to safety concerns.  This solution utilises human-safe 222 nm far-UVC technology which has been shown to be able to effectively inactivate airborne pathogens while maintaining safety since it does not penetrate the outer layer of human skin or eyes. This allows for continuous disinfection of air in occupied spaces. By integrating 222 nm far-UVC technology into HVAC system, including air purification, air monitoring and IoT management platforms, the company offers a complete solution for clean and safe air. With integrated capabilities in both R&D and manufacturing, the company can provide tailor-made solutions for different industry applications. They are seeking collaborations with real estate developers, chain restaurant operators and pathogenic air sampling technology experts to further develop and commercialise this solution. Human-safe 222 nm Far-UVC: An effective and direct disinfection technology, 24x7, no downtime   Green Technology: No chemicals, no mercury, and ozone free Air Quality Monitoring: Multiple sensors IAQ control system New Fresh Air System: Does not rely on fresh air ventilation   Smart IoT System: Enable optimisation of air purification effectiveness and energy efficiency  Reduce Carbon Emission:  Green technology, energy saving This solution could be deployed across various industries, including, but not limited to: Commercial/Residential Complexes Hospitals Hotels and Hospitality Educational Institutions F&B and Catering Operators Indoor Recreational Facilities In addition to indoor occupied spaces, the solution is also applicable in sectors such as the food industry, cold chain, and logistics centres, where secondary pollutants are the major sources of contamination. With the ability to achieve higher number of equivalent air changes, the utilisation of far-UVC for air disinfection offers a more cost effective and energy saving solution for indoor air quality control as compared to traditional air purification methods and reliance on ventilation.  222nm, far-uvc, iaq, covid, flu Green Building, Heating, Ventilation & Air-conditioning, Indoor Environment Quality, Sustainability, Sustainable Living
Biomaterial-based Artificial Cells for Cell Modulation and Expansion
Immune cell activation and expansion for cell therapy is a strictly regulated process. It demands costly and labour-intensive optimization of cell culture conditions. Major limitations of these processes are cell quality and results consistency. Large amounts of expenses were spent on culture conditions, cell characterizations and quality control (QC) with differing culture protocols and recipes in growing CAR-T cells. This technology has established a biomaterial-based artificial cell platform to replace plastic beads, significantly improving cell stimulation performance. The artificial cells uses polysaccharides, lipids, and proteins to mimic live cells, meeting the demand for reproducibility and standardization while being 100% degradable. To address this gap, a modular, all-signals-in-one microbead-based platform has been developed for the next-generation cell therapy R&D and translation. In this delivery platform design, the modular feature allows rapid ‘plug-and-use’ of multiple surface and soluble signals to grow T-cells ex vivo without the need for extensive setup and integration of culture protocols. This platform aims to provide a seamless and straightforward cell culture experience for the industrial and academic research users to discover new types and applications of immune cell therapy. Additionally, the all-signals-in-one synthetic platform mimics the natural antigen presenting cells to activate and expand T-cells on dish, allowing cell manufacturers to ‘mix-and-grow’ immune cells with reduced effort or technical expertise. This aims to improve the cost-effectiveness and scalability of cell therapy manufacturing. The technology provider is seeking collaborations with cell therapy CDMOs/CMOs in licensing and various R&D developments. The artificial cells are a game-changer in cell therapy, offering a sustainable and environmentally friendly alternative to plastic beads. The core of these cells is made of hydrogel, a biodegradable material that mimics the size and texture of live cells. The hydrogel core is treated with special anchors to allow the coating of lipids, recreating the fluid lipid membrane of real cells. The required activation signals are then docked onto this mobile membrane via avidin-biotin interaction, presenting the signals in the most 'natural' way possible. By mimicking cell-cell interactions, the artificial cells provide enhanced quality signals to target cells. The modular design allows for easy customization of surface signals, enabling selective growth of specific cell types. This versatile platform opens doors to discovering and testing new signal pathways and isolating specific cell types. The technology provider now offers a product for T cell activation and expansion, and is developing working prototypes for regulatory T cell and NK cell activation and expansion. The hydrogel-based artificial cells are not only biodegradable but also have the potential for in vivo immunomodulation, paving the way for vaccines for cancers and autoimmune diseases. This technology empowers researchers to grow better cells quicker and discover specific cell subtypes. Cell therapy manufacturers seeking competitive edges in production speed and quality are ideal commercial partners for this innovative and eco-friendly platform. The proprietary microbead-based platform functions as an artificial cell, with its fluidic membrane surface signals presentation and controlled-released soluble signals. The platform application includes but not limited to: Cell therapy manufacturing: Microbeads can be used to support and supplement ex vivo T-cells activation and expansion. Cell-based therapies and regenerative medicine: Microbeads can be engineered to mimic the functions of specific cell types, such as T-cells for immunotherapy, pancreatic cells for diabetes and glial cells for neuron repair. Versatile high-throughput screening platform bridging in-silica signals discovery and in-vitro validation: The ‘plug-and-use’ microbead-based platform feature, together with the versatility avidin-biotin technology and accessibility of commercial biotinylated recombinant proteins and antibodies enable rapid in vitro tests of novel biochemical signals and combinations on cell functions.   Cell therapy is the next pillar of medicine for the treatment of chronic diseases, such as cancer, autoimmune disorders etc.  The cell expansion market was valued at 41.3B USD in 2021 with a CAGR of 12.6%. Nonetheless, many cell therapeutics are still in the discovery and pre-clinical phase. The clinical translation is hampered by suboptimal culture process, unstandardized protocol, limitations of research tools and ex vivo signals delivery platform and high demand of technical expertise. The predominant player in cell expansion and activation market is the magnetic microbeads with emerging alternatives such as antibody tetramers, polymeric nanomatrix, nanosystems with varying shapes/size/stiffness to expand the cell growth tools, facilitate R&D and translational research of cell therapy. This biomaterial-based artificial cell platform revolutionizes cell therapy by providing a sustainable, eco-friendly, and high-performance alternative to current synthetic solutions. Key Advantages: Environmentally Friendly: 100% biodegradable, mitigating the environmental impact of plastic beads. Versatility: Enables the expansion of diverse cell types unserved by current plastic bead-based solutions, such as tumor infiltrating lymphocytes (TILs), natural killer (NK) cells and regulatory T cells. Superior Performance: Up to 2 times faster immune cell expansion compared to state-of-the-art plastic microbeads, with less cell exhaustion. Streamlined Process: Eliminates the need for de-beading, as the hydrogel-based artificial cells degrade at predetermined timepoints. This artificial cell platform empowers researchers and cell therapy manufacturers to: Contribute to a more sustainable and eco-friendly future in cell therapy. Expand diverse immune cells faster and more efficiently. Produce higher quality cells with less exhaustion. Grow challenging cell types, such as NK cells, with the ability to re-stimulate growth. Simplify their processes by eliminating the need for de-beading. Cell and Gene Therapy, Biomaterials, Immune Cell Therapy, Artificial Antigen Presenting Cells, Cell Expansion, Cell Culture, CGT, Advanced Medicinal Products, ATMPs, CAR-T, CAR-NK, Replacing Plastics, Microcarrier Healthcare, Pharmaceuticals & Therapeutics, Life Sciences, Industrial Biotech Methods & Processes, Biotech Research Reagents & Tools
Graphene Oxide Materials for Industrial Applications
This technology focuses on the production of high-quality graphene oxide (GO) and reduced graphene oxide (rGO), designed for various industrial applications. Graphene oxide demonstrates superior electrical, thermal, and mechanical properties, making it an ideal candidate for industries such as electronics, energy storage, coatings, and composites. By reducing GO to rGO, its conductive properties can be enhanced. With the rising demand for advanced nanomaterials that enhance performance while supporting sustainable manufacturing practices, this technology ensures consistent quality and cost-effectiveness of GO and rGO for commercial use. The technology owner is seeking for joint R&D collaborations with industrial manufacturers and companies focused on sustainable materials innovation. Target partners include those in electronics, energy, and materials science sectors, interested in integrating graphene oxide into their new product development pipeline. The technology focuses on the process and production of graphene oxide in both powder and dispersion forms. Some features of the GO include: Can be reduced to rGO to enhance conductive properties Excellent dispersibility in water, ideal for integration into coatings, composite materials, and energy storage solutions Customisable to meet specific industrial needs i.e., varying particle sizes and surface chemistries This graphene oxide technology is applicable across several sectors, including electronics, energy storage, paints and coatings, water filtration, and composites. It enhances mechanical strength and conductivity, providing industries with innovative solutions for next-generation batteries, conductive inks, and advanced coatings. Industries prioritizing sustainability and high-performance materials can leverage this technology to improve efficiency, durability, and eco-friendliness in their products. This technology offers unparalleled scalability, customization, and quality control, providing industries with a reliable source of high-performance, environmentally friendly materials. By integrating graphene oxide into various applications, companies can significantly improve the durability, conductivity, and sustainability of their products, thus gaining a competitive edge. graphene oxide, reduced graphene oxide, nanomaterials, conductive, energy storage, coatings Materials, Semiconductors, Nano Materials, Manufacturing, Chemical Processes
Fungal-like Adhesive Materials (FLAM)
Fungal-like Adhesive Materials (FLAM) represent an innovative family of materials inspired by the cell walls of fungus-like oomycetes. FLAMs are engineered by organizing the two most abundant and widely available natural molecules in their native configuration, resulting in a material that is lightweight, durable, and highly cost-effective. This groundbreaking composite is fully biodegradable, eliminating the need for organic solvents or synthetic materials, making it an eco-friendly alternative. FLAM can be locally produced as part of natural ecological cycles, contributing to sustainable manufacturing and ensuring long-term resource security for industries. In addition to its sustainability benefits, FLAM’s versatility allows it to be easily molded or processed with traditional manufacturing techniques, opening the door to a wide range of applications across various industries. This technology has been locally produced in Singapore as a by-product of waste management. The technology owner is looking for collaboration in test-bedding. FLAM can replace the use of plastic and wood in many applications.  Good strength-to-weight ratio: Inspired by the cell walls of fungus-like oomycetes by combining cellulose and chitin to give a lightweight and strong material. Biodegradable: Fully biodegradable composite with no synthetic additives. Non-toxic: Adding small amounts of a chitinous molecules enables the use of cellulose without any chemical modification and without the use of harmful solvents.  Easy processing: Compability with wood-working machinery and traditional manufacturing methods. FLAM can replace the use of wood in most applications, such as but not limited to: Furniture Architectural components  General and food packaging  Daily household items Large industrial parts: e.g. windmill blades, impact resistors Eco-friendly: Non-toxic, biodegradable material. Lightweight and strong: Able to replace wood and plastic material in most applications. Cost effective: Comparable to high density polyurethane foam. sustainable material, sustainable, biomaterial, FLAM, eco-friendly, biodegradable Materials, Bio Materials, Sustainability, Low Carbon Economy
Bioactive Superoxide Dismutase Enzyme for Cosmetics and Supplements
Superoxide dismutase (SOD) is a key antioxidant enzyme that protects cells from oxidative stress by catalysing the conversion of superoxide radicals into less harmful molecules like oxygen and hydrogen peroxide. These radicals are produced during normal cellular metabolism but can cause significant damage to DNA, proteins, and lipids if not neutralised. SOD helps maintain cellular integrity by reducing this damage, supporting overall health and longevity. Given its role in protecting cell damage, SOD has been utilised in skincare products, cosmeceuticals, dietary supplements, medical and therapeutic products as well as functional foods. Current methods to produce SOD include natural extraction from plants, microbial fermentation and recombinant DNA technology. However, challenges such as low yield, variation in quality and concentration, high costs and regulatory issues still remain. The technology owner uses specific strains of microorganism and advanced biotechnology processes to produce SOD at high yields via fermentation in a sustainable and efficient manner. The enzyme is then extracted and concentrated during downstream processing. This technology could ensure a consistent and scalable supply of SOD for commercial use. The company is seeking collaborations with skincare brands and cosmetic manufacturers interested in co-developing or licensing the technology for mass-market production and distribution. Sustainable and efficient manufacturing: Produced through microbial fermentation using specific and proprietary microorganisms to ensure high yield and purity. High enzyme activity: SOD activity is measured in units (U), typically ranging from 2,000 to 20,000 U/ml, depending on the downstream process, and intended application. pH stable: Active across a wide pH range, typically stable between pH 4.5 to 8.5, making it suitable for various formulations in supplements and cosmetics. Temperature stable: Optimal activity at temperatures between 20°C and 40°C. Some formulations may include stabilisers to maintain activity at higher temperatures. Water soluble: Allowing easy incorporation into aqueous formulations for cosmetics or supplements. Varied formats: Available in liquid concentrate or lyophilised (freeze-dried) powder form, depending on application and customer requirements. Long shelf life: Typically 12-24 months when stored at -20°C for lyophilised forms, with stability maintained through proper storage and packaging. Beyond its biological role, SOD has applications in nutraceuticals and dietary supplements. It could be used to enhance the body's natural defence mechanisms, particularly in combating oxidative stress that contributes to aging and chronic conditions. SOD supplements have potential to reduce inflammation, improve immune function, and support joint health. Some studies suggest that SOD may help mitigate symptoms of conditions like arthritis, asthma, and exercise-induced muscle damage.  In addition to health supplements, SOD is also utilised in the cosmetic industry due to its skin-protective properties. It helps reduce the impact of environmental factors, such as UV radiation and pollution, which accelerate skin aging. There are also potential pharmaceutical applications for reducing oxidative stress. The global market for superoxide dismutase (SOD) is experiencing significant growth, driven by increasing consumer demand for natural antioxidants, health supplements, sports nutrition, and anti-aging solutions. Superoxide dismutase market size was valued at USD 100 Billion in 2023 and is expected to reach USD 145.48 Billion by the end of 2030 with a CAGR of 5.6% (Verified Market Reports, 2024). Consumers are also leaning towards eco-friendly, naturally sourced, and sustainably produced products. SOD, produced via fermentation, aligns with this demand, offering a clean, green alternative to synthetic antioxidants, positioning it favourably in the market. Its unique properties as a potent antioxidant, coupled with advancements in production and delivery methods, position it as a high-value ingredient in the expanding nutraceutical, cosmetic, and pharmaceutical markets. Sustained action: Unlike non-enzymatic antioxidants like vitamin C or E, which are consumed in the process of neutralising free radicals, SOD continues to work through a catalytic cycle. This offers long-lasting protection against oxidative damage at lower dosages. Targeted oxidative stress protection: SOD directly neutralises superoxide radicals, one of the reactive oxygen species (ROS) that contribute to chronic inflammation, aging, and various diseases. Traditional antioxidants are less selective and less effective at targeting this specific radical. Versatile applications: SOD can be used in diverse formulations, from dietary supplements to topical skincare products which broaden its application in health, wellness, and cosmetics industries. Personal Care, Cosmetics & Hair, Nutrition & Health Supplements, Life Sciences, Industrial Biotech Methods & Processes, Sustainability, Sustainable Living
An Antibody Target for Rapid Diagnosis of Liver Fluke Infection
Liver Fluke Infection (Opisthorchis viverrine) caused by the ingestion of raw or uncooked fish containing parasitic worms is a significant health problem in several countries, especially Southeast Asia. This infection while not deadly, can cause acute gastro-hepatic inflammation and long-term infection leading to carcinogenesis of an aggressive bile duct cancer (Cholangiocarcinoma-CCA) if left undiagnosed and untreated. The lifespan of the human liver fluke ranges from 9 to 13.5 years. Hence, early diagnosis of O. viverrini infection is valuable in preventing the infection from worsening and causing complications. Current diagnostic method uses stool examination (restricted by low parasite egg numbers in the specimen), imaging tests of liver and blood tests for antibodies. Cysteine protease is a group of protease enzymes characterized in numerous infectious pathogens. This technology has discovered a single-chain variable fragment (scFv) antibody target against cathepsin F of O. viverrini (OvCatF) by using phage display technologies. Cathepsin F is an enzyme with a half-life that is highly released during the infection, detecting this protein could reflect the current infection. This novel scFv antibody holds great potential in the field of parasitology and infectious diseases, and the characterization of their immunological properties could pave the way for the development of an effective rapid diagnostic kit in the future. The technology owner is seeking for medical device companies to develop this potential target as a practical diagnostic procedure for O. viverrini infection in humans in the future. This invention is a mouse single-chain variable fragment (scFv) antibody that specifically recognizes the epitope on the cathepsin F protein of the human liver fluke Opisthorchis viverrini (OvCatF) on amino acid residues 11 to 30. This scFv antibody contains variable fragments (Fv) of both heavy chain (VH) and light chain (VL), which are connected by a disulfide bond to form a single chain. This scFv antibody is selected by biopanning from the murine naïve single-chain variable fragments (scFv) library and produced by recombinant protein technologies. The ultimate objective of this invention is to develop an effective diagnostic tool for opisthorchiasis and cholangiocarcinoma in the future. Antibody for development and diagnosis of Opisthorchis viverrini infection and cholangiocarcinoma (bile duct cancer). Therapeutic antibody for Opisthorchis viverrini infection. The UVP of this developed scFv antibody is such that it recognizes specific epitopes that have never been used, conserves less than the other parasites, and make low cross-reactivities. The evaluation of specific recognition of the particular epitopes and detection limits by both computational and laboratory performances demonstrated that the selected recombinant scFv antibodies against OvCatF could bind specifically to rOvCatF, and the lowest detection concentration in the study was only 100ng. This target antibody candiate has the potential to be commercialised for early rapid diagnosis of parasitic infectious disease through the development of a rapid test kit.    Single-chain variable fragment (scFv) antibody, Opisthorchis viverrini, Cathepsin F, Liver Fluke Infection Healthcare, Diagnostics, Medical Devices, Pharmaceuticals & Therapeutics
Multi-Material Micro Additive Manufacturing with Micro Resolution
The rapid growth of the Internet of Things (IoT), 5G, and Artificial Intelligence (AI) is driving the miniaturization, integration, and diversification of electronic devices. Till date the fabrication of electronics parts is largely based on traditional methods which does not lead themselves well to the construction of 3D electronic structures. Printed electronics are largely based on non-functional printing technologies which are optimised for 2D printing. Despite the potential, current 3D printing technologies face challenges in material compatibility, resolution, and complexity, making it difficult to create intricate, multi-material electronic devices. A novel approach using selective metal deposition (electroless deposition) combined with projection micro-stereolithography (PµSL) 3D printing offers a solution to address many of the challenges faced. This technology allows the creation of complex metal-plastic hybrid microstructures, potentially extending to other material combinations such as ceramic-metal, glass-metal, and semiconductor-metal hybrids, advancing the capabilities of 3D printed electronics. Besides, the 3D fabrication technique, the other core aspect of the solution included the know-how to formulate the special precursor materials that will allow metallic portions to be printed in-situ. These will combine to form hybrid structures that are functional thereby making it possible to create functional 3D parts. The technology owner is seeking partners with complex applications that involved functional 3D parts to co-create and develop the new applications with them using this technology.     The technology platform features an innovative approach for creating micro-hybrid devices through multiphase and multi-material integration. The core of the additive manufacturing technique involved the combination of UV light-based projection micro-stereolithography (PµSL) combined with electroless deposition method. It employs active precursor materials, specifically an active polymer that induces selective metal deposition, acting as a bridge between plastic and metal. Key technical features include: Multiphase and Multi-Material Integration: Enables the fabrication of devices with diverse material properties (e.g., conductive, insulating, and structural) in a single manufacturing process. High-Resolution Accuracy: Achieves micron-level precision, essential for producing complex, next-generation electronic components. Multifunctional Material Compatibility: Supports a wide range of materials, including conductive metals, ceramics, and advanced polymers, allowing for the creation of multifunctional devices. Enhanced Design Flexibility: Overcomes traditional manufacturing limitations, enabling the creation of complex geometries and hybrid material designs tailored for specific electronic functions. Scalability and Customization: Facilitates rapid prototyping, scalable production, and customized solutions, particularly for niche applications. Largest work piece: 100mm x 100mm x 100mm Smallest resolution: 2.5um Its potential applications include but are not limited to: Electronics Manufacturing 3D Electronics Intelligent Manufacturing for Robotics Medical Devices Semiconductor Manufacturing Automotive Energy Storage & Management Internet of Things (IoT) Devices Fast Fashion Jewellery & Accessories The technology can revolutionize the production of electronic devices by seamlessly integrating metals and plastics into complex, high-resolution microstructures. This process combines multi-material 3D printing with in-situ metal deposition to provide unrivalled design flexibility, precision and efficiency. By overcoming traditional manufacturing constraints, this technology delivers highly customizable, functional components that can set a new benchmark in the production of advanced electronics. Multi-material 3D Printing, Selective Metallization, Microstructures, Hybrids, Electronic Devices, Sensors, 3D Printed Jewellery Materials, Semiconductors, Plastics & Elastomers, Metals & Alloys, Manufacturing, Additive Manufacturing
AI-Based Early Intrusion Detection for Industrial Control System Communications
The trend for embracing industrial digitalisation and automation is increasing due to enhancement in productivity and operational efficiency it brings. However, as industries increasingly rely on more interconnected systems, the potential risks associated with cyber-attacks and system anomalies have grown significantly. With no method to monitor, verify and neutralise these digital attacks, this makes them more vulnerable which can potentially cripple their critical infrastructures. The technology owner has developed a technology solution that leverages on advanced AI-driven technology to provide a robust defence mechanism, ensuring seamless and secure interactions between Information Technology (IT) and Operational Technology (OT) layers. Through the use of their proprietary AI algorithm, it is able to detect and neutralise anomalous network packets with the ability to incrementally learn in real-time. This not only results in preventing potential damage to critical industrial systems but also ensures continuity in production processes, thereby avoiding costly downtime and maintaining productivity. This technology solution helps businesses meet stringent cybersecurity compliance requirements, providing long-term cost-saving and peace of mind. The technology owner is currently undergoing pilot tests for critical water infrastructures, locally and overseas, by integrating this technology solution to existing industrial IT-OT control system. The technology owner is seeking industrial partners who are either open to explore integration into their critical infrastructure enhance their IT-OT cybersecurity or open to explore licensing opportunities. The technology solution to detect and neutralise anomalous network packets have the following capabilities: Real-Time Network Packet Decoding: Decodes network packets as they traverse the IT-OT layers, including PLCs, workstations, SCADA systems, and HMIs, ensuring that only legitimate data reaches its destination. AI-Driven Anomaly Detection: Utilizes advanced artificial intelligence to continuously monitor and analyze network packets flowing through IT-OT interaction layers, identifying any anomalies in real-time. Threat Detection and Intention Extraction: Detects potential cyber threats and extracts the attacker's intent from the anomalous packets, providing critical insights into the nature of the attack. Automated Threat Response: Automatically reports detected threats to plant management and discards malicious packets, preventing them from causing operational disruptions or pushing the plant into an anomalous state. Seamless Integration: Designed for easy integration into existing IT-OT infrastructures, the solution ensures minimal disruption during deployment and compatibility with a wide range of industrial systems. High Reliability and Precision: Offers high accuracy in anomaly detection with minimal false positives, ensuring that the critical infrastructure operates smoothly without unnecessary interruptions. Scalable Architecture: The solution can be scaled to fit different industrial environments, from small facilities to large, complex operations, ensuring robust security across various scales of deployment. The technology solution’s AI-driven anomaly detection and real-time monitoring capabilities make it an essential solution for safeguarding the interaction layers between IT and OT systems. Its ability to detect and neutralize threats before they impact industrial operations ensures the continued security and efficiency of critical infrastructure. This technology is particularly valuable in environments where seamless IT-OT integration and protection against cyber threats are crucial. The applications of the IT-OT Bridge include, but are not limited to: Energy and Utilities: Power plants, electrical grids, water treatment facilities, renewable energy systems. Oil and Gas: Drilling operations, refining processes, pipeline monitoring, distribution networks. Transportation and Logistics: Automated control systems for railways, ports, warehouses, and supply chain management. Chemical Processing: Reaction monitoring, safety systems, quality control in chemical production. Manufacturing: Production lines, assembly processes, quality control systems. The technology solution’s AI-driven ability to proactively detect and neutralise anomalous network packets before they can cause harm in real-time helps enhance the cybersecurity of IT-OT communication within any critical infrastructures. The proprietary AI algorithm enables incremental learning to further improve its high accuracy and precision with minimal false positives. With its seamless integration and scalable architecture, the deployment time required is reduced and can be scaled to fit various industrial environment, ensuring a reliable protection against potential cyber threat and ensuring the continuity and safety of any essential industrial operations. Infocomm, Security & Privacy, Networks & Communications, Artificial Intelligence
Close menu